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ABSTRACT
The potential impact of nanotechnology in the field of
urology is broad with diagnostic and therapeutic benefits
that have only recently begun to be explored. Application
of nanotechnology principles to tissue and vessel sealing
during laparoscopic procedures may reduce associated
thermal injury and inflammatory response. We report our
initial experience using the EnSeal Tissue Sealing and
Hemostasis System during laparoscopic nephrectomy and
discuss its potential advantages and disadvantages com-
pared with those of contemporary technologies.
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INTRODUCTION
The term nanotechnology describes the application of
functional materials, devices, and systems through the
control of matter at the nanometer scale.1 The potential
uses of nanotechnology are broad, and over the past 5
years urological applications have included body or organ
imaging and labeling as adjuncts for diagnosis,2 advanced
delivery of therapeutic agents in prostate cancer,3 and
bioassays for the detection of prostate-specific antigen.4
Recently, the utility of nanotechnology has expanded to
include vessel-sealing systems for application during lapa-
roscopic procedures. We describe our experience using
the EnSeal Tissue Sealing and Hemostasis System (SurgRx
Inc., Redwood City, CA) during laparoscopic nephrec-
tomy and discuss the potential advantages and disadvan-
tages for tissue dissection and vessel sealing that this
novel technology affords.
CASE REPORT
An 81-year-old male was referred to our institution for a
renal mass incidentally discovered during an abdominal
pain workup. Past medical history was significant for
hypertension, and he had no previous abdominal surger-
ies. Computerized tomography scan of the abdomen and
pelvis with intravenous contrast (Figure 1) revealed a
solid, enhancing, 3-cm lesion in the posterior medial up-
per pole of the left kidney consistent with renal cell
carcinoma. No evidence was present of renal vein inva-
sion or retroperitoneal lymphadenopathy. After extensive
discussion regarding surgical approach including cryo-
therapy and partial nephrectomy, the decision was made
to proceed with a laparoscopic left radical nephrectomy.
The patient was placed in the right lateral decubitus po-
sition, and 12-mm periumbilical, 12-mm left upper quad-
rant, and 5-mm superior midline ports were placed using
a Veress needle and under direct vision without difficulty.
Using the EnSeal, the white line of Toldt was incised, and
the descending colon was reflected off of the kidney
medially down to the level of the internal inguinal ring.
Using the left gonadal vein as a landmark, the left ureter
was identified and dissection was continued superiorly to
the level of the renal hilum exclusively using the EnSeal
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CASE REPORTfor both sealing and dividing tissue. The renal vessels
were transected after locking polymer Hem-o-lok clips
(Teleflex Medical, Research Triangle Park, NC) were ap-
plied. Once hilar transaction was complete, the superior
and lateral renal attachments were dissected by using the
EnSeal. After a clip was placed at the inferior aspect of the
left ureter, the ureter was transected, and all remaining
medial and inferior attachments were dissected using the
EnSeal. The kidney was placed in a 15-mm Endo Catch
bag (Tyco Healthcare, Norwalk, CT) and removed
through an extended periumbilical incision. The renal
fossa was re-examined to ensure adequate hemostasis,
and the ports were removed under direct division. Esti-
mated blood loss was negligible (20 mL).
The patient was discharged with a creatinine of 1.7 mg/dL
and a hematocrit of 39.1 x 10
9 cells/L on postoperative day
3 after an uncomplicated hospital course. Pathology re-
vealed pT1b clear cell conventional renal cell carcinoma
with a papillary growth pattern. At his first follow-up visit,
the patient’s creatinine was 1.6 mg/dL, and he reported no
complaints.
DISCUSSION
With the rapid expansion of laparoscopy in urology, safe
and reliable methods of obtaining minimally invasive op-
erative hemostasis are needed. Because traditional meth-
ods of controlling bleeding, such as manual pressure,
tying, and suture ligation, are not as easily applied in a
minimally invasive setting, a heavy reliance on tissue and
vessel coagulation is necessary. However, the monopolar,
bipolar, and ultrasonic devices currently available for tis-
sue and vessel sealing deliver energy at high temperatures
to denature tissue proteins and form a coagulated seal,
which can result in unwanted collateral thermal damage,
sticking and charring, excessive smoke, and insufficient
vessel sealing.5,6
The EnSeal Tissue Sealing and Hemostasis System uses
millions of nanometer-sized particles embedded in a bi-
polar temperature coefficient matrix (Smart Electrode
Technology, Figure 2). The cutting mechanism is in the
shape of an “I”-beam, utilizing high and equal tissue
compression to enhance the seal as the blade is advanced
along the length of the jaw (Figure 3). Current flow is
only active when the device jaws are closed and is mod-
ulated at the tissue-electrode interface by nanoparticles
that locally interrupt current flow to tissue when temper-
atures exceed 100°C. This allows sealing and transection
to occur in a single step and simultaneous current regu-
lation minimizing collateral thermal spread and tissue
damage. A recent comparison of maximum temperature
and thermal spread during vessel sealing between the
EnSeal, Gyrus Bipolar Cutting Forceps (ACMI-Gyrus, Ma-
ple Grove, MN), Ligasure 5, and SonoSurg Ultrasonic Scis-
sors (Olympus Surgical & Industrial America Inc., Orange-
burg, NY) in a porcine model reported that the EnSeal
produces mean lower peak temperatures (86.9°C versus
96.9°C to 180°C) and reduced mean thermal spread to
surrounding tissues (1.10 mm versus 2.78 mm to 3.23
mm).7 Because tissue temperature is prevented from
reaching potentially damaging levels, thermal spread and
charring are minimized. Denes et al8 evaluated the vessel
sealing performance of the EnSeal in a porcine model and
reported that the sealed vessel walls are capable of with-
standing mean burst pressures greater than 900 mm Hg for
vessels less than 7 mm in diameter.
In its closest reported application, the EnSeal has been
used to achieve hemostasis of the dorsal venous complex
during the robotic-assisted laparoscopic prostatectomy
equal to 30 reviewed cases of stapler ligation.9 In our
patient, this technology was used to achieve hemostasis in
dissecting and dividing all renal and colonic attachments,
including those around the renal hilum. The renal vessels
were traditionally divided after application of clips. Esti-
mated blood loss was minimal, and the renal fossa was
dry upon final examination. We found that the 5-mm
straight jaw EnSeal device proved effective in performing
Figure 1. Computerized tomography scan of the abdomen with
intravenous contrast revealing a solid, enhancing, 3-cm lesion in
the posterior upper pole of the left kidney consistent with renal
cell carcinoma.
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renal tissues (fibroadipose, peritoneal, and lymphatic).
With the exception of the hilar vessels, this device proved
adequate for sealing and transecting small peripheral ves-
sels less than 3 mm, and subjectively, plume production
was minimal compared with previous experiences with
the Harmonic ACE (Ethicon Endo-Surgery, Inc., Somer-
ville, NJ) and monopolar cautery devices. We did find that
after repeated use, dissection became more arduous due
to tissue adherence to the jaws of the device, but recent
modifications including a shorter (3 mm) curved jaw may
provide some improvement.
CONCLUSION
The potential impact of nanotechnology in the field of
urology is wide-ranging with both diagnostic and thera-
peutic benefits. The recent application to tissue and vessel
sealing during laparoscopic procedures may reduce ther-
mal injury and inflammatory response previously associ-
ated with monopolar and bipolar electrocautery. Our ini-
tial experience shows that the EnSeal tissue sealing and
hemostasis system can be safely utilized during laparo-
scopic nephrectomy to achieve hemostasis during dissec-
tion. Further formal evaluation of vessel-sealing capacity
and comparison with known vessel-sealing systems is
warranted.
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